Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Abnormalities and Lrrk2[original query] |
---|
LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample. Parkinsonism & related disorders 2006 Oct 12 (7): 410-9. Goldwurm Stefano, Zini Michela, Di Fonzo Alessio, De Gaspari Danilo, Siri Chiara, Simons Erik J, van Doeselaar Marina, Tesei Silvana, Antonini Angelo, Canesi Margherita, Zecchinelli Anna, Mariani Claudio, Meucci Nicoletta, Sacilotto Giorgio, Cilia Roberto, Isaias Ioannis U, Bonetti A, Sironi Francesca, Ricca Sara, Oostra Ben A, Bonifati Vincenzo, Pezzoli Gian |
Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia. Parkinsonism & related disorders 2009 Feb 15 (2): 105-9. Mellick George D, Siebert Gerhard A, Funayama Manabu, Buchanan Daniel D, Li Yuanzhe, Imamichi Yoko, Yoshino Hiroyo, Silburn Peter A, Hattori Nobuta |
A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry 2010 Apr 81 (4): 391-5. Nishioka Kenya, Kefi Mounir, Jasinska-Myga Barbara, Wider Christian, Vilariño-Güell Carles, Ross Owen A, Heckman Michael G, Middleton Lefkos T, Ishihara-Paul Lianna, Gibson Rachel A, Amouri Rim, Ben Yahmed Samia, Ben Sassi Samia, Zouari Mourad, El Euch Ghada, Farrer Matthew J, Hentati Fayc |
LRRK2 G2019S mutation in Parkinson's disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort. Parkinsonism & related disorders 2010 Dec 16 (10): 676-9. Belarbi Soreya, Hecham Nassima, Lesage Suzanne, Kediha Mohamed I, Smail Nourredine, Benhassine Traki, Ysmail-Dahlouk Farida, Lohman Ebba, Benhabyles Badia, Hamadouche Tarik, Assami Salima, Brice Alexis, Tazir Meri |
Parkinson disease-associated LRRK2 G2019S transgene disrupts marrow myelopoiesis and peripheral Th17 response. Journal of leukocyte biology 2017 10 102 (4): 1093-1102. Park Jeongho, Lee Jang-Won, Cooper Scott C, Broxmeyer Hal E, Cannon Jason R, Kim Chang |
The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study. The Lancet. Neurology 2018 2 17 (4): 309-316. Liu Shu-Ying, Wile Daryl J, Fu Jessie Fanglu, Valerio Jason, Shahinfard Elham, McCormick Siobhan, Mabrouk Rostom, Vafai Nasim, McKenzie Jess, Neilson Nicole, Perez-Soriano Alexandra, Arena Julieta E, Cherkasova Mariya, Chan Piu, Zhang Jing, Zabetian Cyrus P, Aasly Jan O, Wszolek Zbigniew K, McKeown Martin J, Adam Michael J, Ruth Thomas J, Schulzer Michael, Sossi Vesna, Stoessl A J |
Network abnormalities among non-manifesting Parkinson disease related LRRK2 mutation carriers. Human brain mapping 2019 2 40 (8): 2546-2555. Jacob Yael, Rosenberg-Katz Keren, Gurevich Tanya, Helmich Rick C, Bloem Bastiaan R, Orr-Urtreger Avi, Giladi Nir, Mirelman Anat, Hendler Talma, Thaler Avn |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: